Eratex Djaja Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Eratex Djaja Tbk. trades at Rp181 (market cap 239.3B, 594.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Eratex Djaja Tbk. is far larger — about 2.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ERTX | SCPI | |
|---|---|---|
Market Cap | 239.3B | 104.4B |
Volume | 594.1K | — |
Lot | 5.94K | — |
Turnover | 108.21M | — |
Average Price | 182.14 | — |
Value | 108.21M | — |
Indicative Equilibrium Price | 181 | — |
Indicative Equilibrium Volume | 864 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Eratex Djaja Tbk (the "Entity") was established in the framework of Foreign Capital Investment Law No.1, 1967 by Notarial Deed No.7 dated October 12, 1972 based on Deed prepared by Koerniatini Karim, Public Notary in Jakarta. Founded in 1972 as a joint venture company between PT Private Development Finance Company of Indonesia Ltd. and Limmen Investment Ltd., Unisouh Holding Ltd., Eastern Cotton Mills Ltd. Yarn spinning factory was built in 1973 on 17 ha of land in Probolinggo.
Read more on ERTX →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →